EDMA (European Diagnostic Manufacturers Association) concern at low IVD (in vitro diagnostic) use
This article was originally published in Clinica
Executive Summary
"European spending on in vitro diagnostics is clearly too low," says the European Diagnostic Manufacturers Association (EDMA) in notes accompanying its recently published 2000 annual audit. Short-term cost-cutting has been the motive, but health systems must prepare to respond to the longer term rise in demand for in vitro testing, says the Brussels-based association.